Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
Rischin D, Hughes BGM, Basset-Séguin N, Schadendorf D, Bowyer S, Trabelsi Messai S, Meier F, Eigentler TK, Casado Echarren V, Stein B, Beylot-Barry M, Dalac S, Dréno B, Migden MR, Hauschild A, Schmults CD, Lim AM, Yoo SY, Paccaly AJ, Papachristos A, Nguyen JH, Okoye E, Seebach F, Booth J, Lowy I, Fury MG, Guminski A. Rischin D, et al. Among authors: fury mg. J Immunother Cancer. 2024 Mar 11;12(3):e008325. doi: 10.1136/jitc-2023-008325. J Immunother Cancer. 2024. PMID: 38471711 Free PMC article. Clinical Trial.
NCCN Task Force Report: mTOR inhibition in solid tumors.
Figlin RA, Brown E, Armstrong AJ, Akerley W, Benson AB 3rd, Burstein HJ, Ettinger DS, Febbo PG, Fury MG, Hudes GR, Kies MS, Kwak EL, Morgan RJ Jr, Mortimer J, Reckamp K, Venook AP, Worden F, Yen Y. Figlin RA, et al. Among authors: fury mg. J Natl Compr Canc Netw. 2008 Sep;6 Suppl 5:S1-20; quiz S21-2. J Natl Compr Canc Netw. 2008. PMID: 18926092 Review.
U6 snRNA maturation and stability.
Fury MG, Zieve GW. Fury MG, et al. Exp Cell Res. 1996 Oct 10;228(1):160-3. doi: 10.1006/excr.1996.0311. Exp Cell Res. 1996. PMID: 8892983
A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors.
Fury MG, Lipton A, Smith KM, Winston CB, Pfister DG. Fury MG, et al. Cancer Immunol Immunother. 2008 Feb;57(2):155-63. doi: 10.1007/s00262-007-0357-5. Epub 2007 Jun 30. Cancer Immunol Immunother. 2008. PMID: 17602224 Free PMC article. Clinical Trial.
91 results